Literature DB >> 17827004

Design, synthesis, and biological testing of pyrazoline derivatives of combretastatin-A4.

Marlie Johnson1, Brent Younglove, Lauren Lee, Regan LeBlanc, Herman Holt, Patrice Hills, Hilary Mackay, Toni Brown, Susan L Mooberry, Moses Lee.   

Abstract

Fourteen N-acetylated and non-acetylated 3,4,5-tri- or 2,5-dimethoxypyrazoline analogs of combretastatin-A4 (1) were synthesized. A non-acetylated derivative (5a) with the same substituents as CA-4 (1) was the most active compound in the series, with IC(50) values of 2.1 and 0.5 microM in B16 and L1210 cell lines, respectively. In contrast, a similar compound with an acetyl group at N1 of the pyrazoline ring (6g) showed poor activity in the cell lines studied. A cell-based assay indicated that compound 5a caused extensive microtubule depolymerization with an EC(50) value of 7.1 microM in A-10 cells while no activity was seen with the acetylated compound. Molecular modeling studies showed that these compounds possess a twisted conformation similar to CA-4 (1).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17827004     DOI: 10.1016/j.bmcl.2007.07.105

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  14 in total

1.  Design, synthesis, and biological evaluations of 2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoline analogs of combretastatin-A4.

Authors:  Lauren Lee; Lyda M Robb; Megan Lee; Ryan Davis; Hilary Mackay; Sameer Chavda; Balaji Babu; Erin L O'Brien; April L Risinger; Susan L Mooberry; Moses Lee
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

Review 2.  An overview of tubulin inhibitors that interact with the colchicine binding site.

Authors:  Yan Lu; Jianjun Chen; Min Xiao; Wei Li; Duane D Miller
Journal:  Pharm Res       Date:  2012-07-20       Impact factor: 4.200

3.  1-Acetyl-5-ferrocenyl-3-phenyl-2-pyrazoline.

Authors:  Nevzat Karadayı; Günseli Turgut Cin; Seda Demirel; Abban Cakıcı; Orhan Büyükgüngör
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-01-08

4.  Syntheses and cytotoxic properties of the curcumin analogs 2,6-bis(benzylidene)-4-phenylcyclohexanones.

Authors:  Ryan Davis; Umashankar Das; Hilary Mackay; Toni Brown; Susan L Mooberry; Jonathan R Dimmock; Moses Lee; Hari Pati
Journal:  Arch Pharm (Weinheim)       Date:  2008-07       Impact factor: 3.751

5.  Stereoselective synthesis of cis- or trans-3,5-disubstituted pyrazolidines via Pd-catalyzed carboamination reactions: use of allylic strain to control product stereochemistry through N-substituent manipulation.

Authors:  Natalie C Giampietro; John P Wolfe
Journal:  J Am Chem Soc       Date:  2008-09-06       Impact factor: 15.419

6.  Antitumor, Analgesic, and Anti-inflammatory Activities of Synthesized Pyrazolines.

Authors:  Pj Jainey; Ik Bhat
Journal:  J Young Pharm       Date:  2012-04

7.  Design, synthesis and molecular docking of novel diarylcyclohexenone and diarylindazole derivatives as tubulin polymerization inhibitors.

Authors:  Riham I Ahmed; Essam Eldin A Osman; Fadi M Awadallah; Samir M El-Moghazy
Journal:  J Enzyme Inhib Med Chem       Date:  2016-10-24       Impact factor: 5.051

Review 8.  Recent advances in the therapeutic applications of pyrazolines.

Authors:  Mohamed R Shaaban; Abdelrahman S Mayhoub; Ahmad M Farag
Journal:  Expert Opin Ther Pat       Date:  2012-03-08       Impact factor: 6.674

9.  Organocatalytic cascade aza-Michael/hemiacetal reaction between disubstituted hydrazines and α,β-unsaturated aldehydes: Highly diastereo- and enantioselective synthesis of pyrazolidine derivatives.

Authors:  Zhi-Cong Geng; Jian Chen; Ning Li; Xiao-Fei Huang; Yong Zhang; Ya-Wen Zhang; Xing-Wang Wang
Journal:  Beilstein J Org Chem       Date:  2012-10-09       Impact factor: 2.883

10.  Pyrrolyl Pyrazoline Carbaldehydes as Enoyl-ACP Reductase Inhibitors: Design, Synthesis and Antitubercular Activity.

Authors:  Sheshagiri R Dixit; Shrinivas D Joshi; Venkatarao H Kulkarni; Sunil S Jalalpure; Vijay M Kumbar; Tulasigiriyappa Y Mudaraddi; Mallikarjuna N Nadagouda; Tejraj M Aminabhavi
Journal:  Open Med Chem J       Date:  2017-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.